glp-1 breast cancer recurrence medications may offer benefits beyond weight loss and diabetes management, including improved outcomes for patients who are obese or have type 2 diabetes, according to new research. The study GLP-1s in Breast Cancer: Overall
Description
With many of our users struggling with conditions associated with metabolic, cardiovascular, and systemic health, alternative treatments are being researched that focus on addressing the underlying cause of issues
doi: 10.3390/cells13010065
, Letchford, D
one that should theoretically uphold FDA standards
It activates GLP-1 receptors, leading to increased insulin release from pancreatic beta cells in response to elevated blood sugar levels, making it an excellent treatment for type 2 diabetes
10.1016/j.bbrc.2003.08.111 [DOI] [PubMed] [Google Scholar] 174.Shigeta T, Aoyama M, Bando YK, Monji A, Mitsui T, Takatsu M, et al
